CA1286224C - Utilisation de l'hormone de croissance humaine pour le traitement des personnes intoxiquees - Google Patents

Utilisation de l'hormone de croissance humaine pour le traitement des personnes intoxiquees

Info

Publication number
CA1286224C
CA1286224C CA000533581A CA533581A CA1286224C CA 1286224 C CA1286224 C CA 1286224C CA 000533581 A CA000533581 A CA 000533581A CA 533581 A CA533581 A CA 533581A CA 1286224 C CA1286224 C CA 1286224C
Authority
CA
Canada
Prior art keywords
growth hormone
human growth
use according
intoxicated
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000533581A
Other languages
English (en)
Inventor
Karin Damm Jorgensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordisk Gentofte AS
Original Assignee
Nordisk Gentofte AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/032,053 external-priority patent/US4816439A/en
Application filed by Nordisk Gentofte AS filed Critical Nordisk Gentofte AS
Priority to CA000533581A priority Critical patent/CA1286224C/fr
Application granted granted Critical
Publication of CA1286224C publication Critical patent/CA1286224C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000533581A 1987-03-27 1987-04-01 Utilisation de l'hormone de croissance humaine pour le traitement des personnes intoxiquees Expired - Lifetime CA1286224C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000533581A CA1286224C (fr) 1987-03-27 1987-04-01 Utilisation de l'hormone de croissance humaine pour le traitement des personnes intoxiquees

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/032,053 US4816439A (en) 1987-03-27 1987-03-27 The use of human growth hormone for the treatment of intoxicated individuals
CA000533581A CA1286224C (fr) 1987-03-27 1987-04-01 Utilisation de l'hormone de croissance humaine pour le traitement des personnes intoxiquees

Publications (1)

Publication Number Publication Date
CA1286224C true CA1286224C (fr) 1991-07-16

Family

ID=25671291

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000533581A Expired - Lifetime CA1286224C (fr) 1987-03-27 1987-04-01 Utilisation de l'hormone de croissance humaine pour le traitement des personnes intoxiquees

Country Status (1)

Country Link
CA (1) CA1286224C (fr)

Similar Documents

Publication Publication Date Title
US4816439A (en) The use of human growth hormone for the treatment of intoxicated individuals
Hirai et al. Nasal absorption of insulin in dogs
Ervin et al. Inactivation of gentamicin by penicillins in patients with renal failure
AU2003238862B2 (en) Formulations for amylin agonist peptides
KR100397034B1 (ko) 비강투여용비무기식염용액
US5112804A (en) Pharmaceutical composition and method of intranasal administration
CN101601646B (zh) 治疗糖尿病的鼻腔滴剂及其制备方法
Berman Treatment of New World cutaneous and mucosal leishmaniases
BG60934B2 (bg) Терапевтични състави,съдържащи антрациклинови глюкозиди
LU84546A1 (de) Verwendung von peptiden als medikamente
ES2251715T3 (es) Suspensiones inyectables de efecto prolongado de un analogo de lhrh y un procedimiento para su preparacion.
US6245346B1 (en) Pharmaceutical compositions for the sustained release of insoluble active principles
EP1524987A1 (fr) Formulation pharmaceutique contenant un peptide nasal
CA1286224C (fr) Utilisation de l'hormone de croissance humaine pour le traitement des personnes intoxiquees
US5140008A (en) Human growth hormone unit dose for the treatment of intoxicated individuals
US5908824A (en) Nasally administrable compositions containing physiologically active peptides
US20050118241A1 (en) Platform for transdermal formulations (ptf)
WO1999059543A1 (fr) Formulation pharmaceutique destinee a l'administration par voie nasale
JPH0338255B2 (fr)
JPS63303931A (ja) 経鼻投与用成長ホルモン放出活性物質製剤
JPH05170664A (ja) 安定なペプチド医薬組成物
EP0316030B1 (fr) Produit contenant de la vincristine
JPS63258821A (ja) 鼻腔内投与用薬剤組成物
WO1986003413A1 (fr) Preparations pour l'injection intramusculaire de medicaments, vitamines ou vaccins
RU2057537C1 (ru) Лекарственное средство иммуномодулирующего действия на основе тимозина "тимактид"

Legal Events

Date Code Title Description
MKEX Expiry